Non-myeloablative bone marrow transplantation

Archives of Medical Research

Volumn 34, Issue 6, 2003, Pages 554-557

  Ruiz Argüelles, Guillermo J ^a  

^a Clinica Ruiz   (Mexico)

Author keywords

Allograft; Bone marrow; Non myeloablative; Reduced intensity; Stem cell; Transplantation

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; GANCICLOVIR; IMMUNOGLOBULIN G; MYELOABLATIVE AGENT;

AGE; ALLOGRAFT; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; COST; DONOR; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HUMAN; OUTPATIENT; RECIPIENT; REVIEW; SIDE EFFECT; SPACE; STEM CELL TRANSPLANTATION;

EID: 0347004680     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2003.08.005     Document Type: Review

References (24)

1. Alarcón-Segovia D., Ruiz-Argüelles A., Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol Today. 17:1996;163-164.
2. Thomas E.D. Hematopoietic stem cell transplantation. Sci Am. 272:1995;38-47.
3. Odom L.F., August C.S., Githens J.H., Humbert J.R., Morse H., Peakman D., Sharma B., Rusnak S.L., Johnson F.B. Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man? Lancet. 2:(8089):1978;537-540.
4. Weiden P.L., Sullivan K.M., Fluornoy N., Storb R., Thomas E.D. Antileukemic effect of chronic graft versus host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med. 304:1981;1529-1533.
5. Lichtman M.A., Spivak J.L., Boxer L.A., Shattil S.J., Henderson E.S. Hematology: landmark papers of the twentieth century. 2000;741-747 Academic Press, San Diego, CA, USA.
6. Giralt S., Estey E., Albitar M., van Besien K., Rondón G., Anderlini P., O'Brien S., Khouri I., Gajewski J., Mehra R., Claxton D., Andersson B., Beran M., Przepiorka D., Koller C., Kornblau S., Körbling M., Keating M., Kantarjian H., Champlin R. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood. 89:1997;4531-4536.
7. Slavin S., Nagler A., Naparstek E., Kapelushnik Y., Aker M., Cividelli G., Varadi G., Kirschbaum M., Ackerstein A., Samuel S., Amar A., Brautbar C., Ben-Tal O., Eldor A., Or R. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases. Blood. 91:1998;756-763.
8. Quesenberry P.J., Stewart F.M., Becker P., Emmons R., Hsieh C., Werme K., Habibian H., Reilly J., McAuliffe C., Dooner M., Carlson J., Miller C., Lambert J.F., Colvin G.A., Pang L., Benoit B.O., Zhong S., Wang H., Damon J. Stem cell transplantation without myeloablation in immunocompetent recipients. Giralt S., Slavin S. Nonmyeloablative stem cell transplantation. 2000;11-16 Darwin Scientific Publishing, Abingdon, Oxfordshire, UK.
9. Khouri I.F., Keating M., Korbling M., Przepiorka D., Anderlini P., O'Brien S., Giralt S., Ippoliti C., von Wolff B., Gajewski J., Donato M., Claxton D., Ueno N., Andersson B., Gee A., Champlin R. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 16:1998;2817-2824.
10. Champlin R. Nonmyeloablative chemotherapy with allogeneic hematopoietic transplantation as adoptive immunotherapy for malignancies. Schechter G.P., Hoffman R., Schrier S.L. Hematology 1999. 1999;413-416 The American Society of Hematology Education Program Book, Washington, D.C., USA.
11. Feinstein L., Sandmaier B., Maloney D., McSweeney P.A., Maris M., Flowers C., Radich J., Little M.T., Nash R.A., Cauncey T., Wolfrey A., Georges G., Kiem H.P., Zaucha J.M., Blume K.G., Shizuru J., Niederweiser D., Storb R. Non-myeloablative hematopoietic stem cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect. Ann N Y Acad Sci. 938:2001;328-337.
12. Storb R., Champlin R., Riddell S.R., Murata M., Bryant S., Warren E.H. Non-myeloablative transplants for malignant disease. Schechter G.P., Broudy V.C., Williams M.E. Hematology 2001. 2002;375-391 The American Society of Hematology Education Program Book, Washington, D.C.,USA.
13. Childs R., Barrett J.A. Graft-versus-tumor effects following non-myeloablative stem cell transplantation. Giralt S., Slavin S. Nonmyeloablative stem cell transplantation. 2000;113-126 Darwin Scientific Publishing, Abingdon, Oxfordshire, UK.
14. Childs R., Clave E., Tisdale J., Plante M., Hensel N., Barret A.J. Successful treatment of metastatic renal cell carcinoma with a non-myeloablative allogeneic peripheral blood progenitor cell transplant: evidence for a graft-versus-tumor effect. J Clin Oncol. 17:1999;2044-2051.
15. Georges G.E., Storb R. Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation. Int J Hematol. 77:2003;3-143.
16. Ruiz-Argüelles G.J., Gómez-Almaguer D., López- Martínez B., Cantú-Rodríguez O.G., Jaime-Pérez J.C., González-Llano O. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica. 87:2002;894-896.
17. Gómez-Almaguer D., Ruiz-Argüelles G.J., Tarín-Arzaga L.C., González-Llano O., Jaime-Pérez J.C., López- Martínez B., Cantú-Rodríguez O.G., Herrera-Garza J.L. Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience. Biol Blood Marrow Transplant. 9:2003;157-161.
18. Vindelov L. Allogeneic bone marrow transplantation with reduced conditioning. Eur J Haematol. 66:2001;73-82.
19. Carella A.M., Lerma E., Dejana A., Corsetti M.T., Celesti L., Bruni R., Benvenuto F., Figari O., Parodi C., Carlier P., Florio G., Lercari G., Valbonesi M., Casarino L., De Stefano F., Geniram A., Venturino M., Tedeschi L., Palmieri G., Piaggio G., Podesta M., Frassoni F., Van Lint M.T., Marmont A.M., Bacigalupo A. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias. Haematologica. 83:1998;904-909.
20. Chandy M. Management of hematological diseases in developing countries: socio-economic aspects. Schechter G.P., Hoffman R., Schrier S.L. Hematology 1999. 1999;73-76 Society of Hematology Education Program Book, Washington, D.C., USA.
21. Barr R.D. The importance of lowering costs of stem cell transplantation in developing countries. Int J Hematol. 76:(Suppl 1):2002;365-367.
22. Giralt S. Update of non-myeloablative stem cell transplantation for hematologic malignancies. Int J Hematol. 76:(Suppl 1):2002;368-375.
23. Julbegovic B., Seidenfeld J., Bonnell A., Kumar A. Nonmyeloablative allogeneic stem cell transplantation for hematologic malignancies: a systematic review. Cancer Control. 10:2003;17-41.
24. Spitzer T.R. The expanding applications of non-myeloablative stem cell transplantation. Pediatr Transplant. 7:2003;95-100.